Search for: "Immunex Corp v. Sandoz Inc."
Results 1 - 8
of 8
Sorted by Relevance
|
Sort by Date
6 Jul 2020, 8:53 pm
Sandoz Inc. [read post]
10 Sep 2020, 3:00 am
Immunex Corp., v. [read post]
13 Jul 2020, 1:13 pm
In Immunex Corp. v Sandoz Inc., the Federal Circuit added another layer of complexity to the doctrine, deciding a licensed patent can be treated as a “commonly owned” patent for purposes of obviousness-type double patenting if the licensee controlled prosecution and received “all substantial rights” in the patent. [read post]
15 Feb 2021, 9:52 am
by Dennis crouch Sandoz Inc. v. [read post]
8 Jun 2023, 10:20 am
” Immunex Corp. v. [read post]
15 Apr 2021, 10:51 am
Hikma Pharmaceuticals USA Inc., et al., No. 20-1119 (secondary indicia); Sandoz Inc., et al. v. [read post]
22 Sep 2022, 9:54 am
Sandoz, which produces a biosimilar sold outside of the US called Erelzi, attempted to invalidate the patents, taking their case all the way to the Supreme Court (Sandoz Inc. v Immunex Corp., 20-1110, Supreme Court). [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP) Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
